MALVERN, Pa., Sept. 13, 2024 /PRNewswire/ — Endo, Inc. (“Endo”) (OTCQX: NDOI) announced today that data from a clinical study of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis were presented during the American Orthopaedic Foot & Ankle Society’s (AOFAS)…